Mirum Pharmaceuticals【MIRM】株式ニュース

名称	銘柄コード	市場	種別
Mirum Pharmaceuticals Inc	MIRM	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.41	-1.68%	24.03	09:00:00

始値	安値	高値	終値	前日終値
24.54	23.83	24.95	24.03	24.44

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/01	06:02	BW	Mirum Pharmaceuticals: positive CHMP-Stellungnahme für..
2024/6/01	02:12	BW	Mirum Pharmaceuticals annonce un avis favorable du CHMP pour..
2024/5/31	21:30	BW	Mirum Pharmaceuticals Announces Positive CHMP Opinion for..
2024/5/29	21:30	BW	Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and..
2024/5/18	20:00	BW	Mirum Pharmaceuticals’ LIVMARLI Data Showcased at ESPGHAN..
2024/5/17	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/11	08:30	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/5/09	05:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	05:04	EDGAR2	Form 8-K - Current report
2024/5/09	05:02	BW	Mirum Pharmaceuticals Reports First Quarter 2024 Financial..
2024/5/08	05:10	BW	Mirum Pharmaceuticals to Present at the Citizens JMP Life..
2024/5/07	21:30	BW	Mirum Announces Publication of Phase 3 MARCH Data in The..
2024/5/02	05:10	BW	Mirum Pharmaceuticals to Announce First Quarter 2024..
2024/4/11	10:30	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/4/02	21:30	BW	LIVMARLI (solution orale de maralixibat) de Mirum..
2024/3/25	20:00	GLOBE	Sagimet Biosciences Announces Appointment of Tim Walbert and..
2024/3/14	07:00	BW	Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for..
2024/3/09	09:30	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/3/05	22:00	BW	Mirum Pharmaceuticals to Participate in Upcoming Investor..
2024/2/29	22:30	BW	Hepatology Publishes Six-Year Data Demonstrating Improved..
2024/2/29	07:01	EDGAR2	Form NT 10-K - Notification of inability to timely file Form..
2024/2/29	06:05	EDGAR2	Form 8-K - Current report
2024/2/29	06:03	BW	Mirum Pharmaceuticals Reports Fourth Quarter and Year-End..
2024/2/22	06:05	BW	Mirum Pharmaceuticals to Announce Fourth Quarter and..
2024/2/10	11:15	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/2/06	11:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/06	11:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	11:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	09:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	09:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	09:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	11:30	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/1/17	06:15	EDGAR2	Form 8-K - Current report
2024/1/16	22:30	BW	Mirum Pharmaceuticals Appoints Joanne Quan, MD as Chief..
2024/1/11	09:00	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/1/10	10:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	10:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	10:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/08	22:30	EDGAR2	Form 8-K - Current report
2024/1/08	22:30	BW	Mirum Pharmaceuticals Announces Preliminary Unaudited 2023..
2024/1/03	22:45	BW	Mirum Pharmaceuticals to Present at the 42nd Annual J.P...
2023/12/19	06:06	EDGAR2	Form 8-K - Current report
2023/12/18	22:30	BW	Mirum Pharmaceuticals Announces Data from EMBARK Phase 2b..
2023/12/09	09:30	BW	Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2023/12/07	07:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/05	14:00	BW	LIVMARLI (maralixibat) di Mirum Pharmaceutical è stato..
2023/11/21	06:05	BW	Mirum Pharmaceuticals to Present at the 2023 Evercore ISI..
2023/11/16	10:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/16	10:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/14	04:00	BW	Mirum Pharmaceuticals Presents New Data at The Liver..